Status:
RECRUITING
Metagenomic Analysis of Bacterial Microbiota in Breast Milk
Lead Sponsor:
Centre Hospitalier Sud Francilien
Conditions:
Bacteria in Breast Milk
Eligibility:
All Genders
1+ years
Brief Summary
The aim of this study is to determine the extent to which bacteria in the breast milk microbiota represent an infectious risk for premature infants, by investigating whether they possess virulence gen...
Detailed Description
There are still many unknowns about the exact bacterial composition of breast milk, and the theoretical and real risks represented by its microbiota. In addition to determining the Total Aerobic Flora...
Eligibility Criteria
Inclusion
- Women of legal age who have given birth at the CHSF (or in another establishment) and whose newborn(s) are being cared for in the CHSF's Neonatal Medicine and Intensive Care Unit,
- Women wishing to give their milk to their child,
- Parents who have given their consent for the mother-child couple to take part in the study.
Exclusion
- Mother having received antibiotic therapy in the 3 months prior to delivery, except for those who received injectable antibiotic prophylaxis during delivery.
Key Trial Info
Start Date :
September 8 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06037421
Start Date
September 8 2025
End Date
December 31 2028
Last Update
December 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Sud Francilien
Corbeil-Essonnes, France, France, 91106